35O_PRINVESTIGATING THE UTILITY OF CIRCULATING-FREE TUMOUR-DERIVED DNA (CTDNA) IN PLASMA FOR THE DETECTION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION STATUS IN EUROPEAN AND JAPANESE PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG CANCER (ANSCLC): ASSESS STUDY